Search research articles
Contact Us
Filters
Showing results (41-50 of 58) with videos related to
Page
of 6
Sort By:
ACS Infectious Diseases
|
May 1, 2018
Effects of the 1- N-(4-Amino-2 S-hydroxybutyryl) and 6'- N-(2-Hydroxyethyl) Substituents on Ribosomal Selectivity, Cochleotoxicity, and Antibacterial Activity in the Sisomicin Class of Aminoglycoside Antibiotics
Amr Sonousi, Vikram A Sarpe, Margarita Brilkova, et al.
Environmental Toxicology
|
June 4, 2016
Vestibular dysfunction in the adult CBA/CaJ mouse after lead and cadmium treatment
Katarina E M Klimpel, Min Young Lee, W. Michael King, et al.
Hearing Research
|
June 25, 2008
Age-related auditory pathology in the CBA/J mouse
Su-Hua Sha, Ariane Kanicki, Gary Dootz, et al.
Hearing Research
|
July 18, 2006
Aspirin attenuates gentamicin ototoxicity: from the laboratory to the clinic
Yang Chen, Wei-Guo Huang, Ding-Jun Zha, et al.
The Journal of Biological Chemistry
|
December 5, 2013
Designer aminoglycosides that selectively inhibit cytoplasmic rather than mitochondrial ribosomes show decreased ototoxicity: a strategy for the treatment of genetic diseases
Eli Shulman, Valery Belakhov, Gao Wei, et al.
Neurobiology of Aging
|
February 7, 2012
Alleles that modulate late life hearing in genetically heterogeneous mice
Jochen Schacht, Richard Altschuler, David T Burke, et al.
Scientific Reports
|
June 27, 2019
Auditory metabolomics, an approach to identify acute molecular effects of noise trauma
Lingchao Ji, Ho-Joon Lee, Guoqiang Wan, et al.
Free Radical Biology & Medicine
|
January 15, 2005
Elevation of superoxide dismutase increases acoustic trauma from noise exposure
Tsuyoshi Endo, Takayuki Nakagawa, Fukuichiro Iguchi, et al.
Nucleic Acids Research
|
August 13, 2015
Structural basis for selective targeting of leishmanial ribosomes: aminoglycoside derivatives as promising therapeutics
Moran Shalev, Haim Rozenberg, Boris Smolkin, et al.
Journal of Medicinal Chemistry
|
March 25, 2009
Development of novel aminoglycoside (NB54) with reduced toxicity and enhanced suppression of disease-causing premature stop mutations
Igor Nudelman, Annie Rebibo-Sabbah, Marina Cherniavsky, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 58) with videos related to
Sort By:
Page
of 6
ACS Infectious Diseases
|
May 1, 2018
Effects of the 1- N-(4-Amino-2 S-hydroxybutyryl) and 6'- N-(2-Hydroxyethyl) Substituents on Ribosomal Selectivity, Cochleotoxicity, and Antibacterial Activity in the Sisomicin Class of Aminoglycoside Antibiotics
Amr Sonousi, Vikram A Sarpe, Margarita Brilkova, et al.
Environmental Toxicology
|
June 4, 2016
Vestibular dysfunction in the adult CBA/CaJ mouse after lead and cadmium treatment
Katarina E M Klimpel, Min Young Lee, W. Michael King, et al.
Hearing Research
|
June 25, 2008
Age-related auditory pathology in the CBA/J mouse
Su-Hua Sha, Ariane Kanicki, Gary Dootz, et al.
Hearing Research
|
July 18, 2006
Aspirin attenuates gentamicin ototoxicity: from the laboratory to the clinic
Yang Chen, Wei-Guo Huang, Ding-Jun Zha, et al.
The Journal of Biological Chemistry
|
December 5, 2013
Designer aminoglycosides that selectively inhibit cytoplasmic rather than mitochondrial ribosomes show decreased ototoxicity: a strategy for the treatment of genetic diseases
Eli Shulman, Valery Belakhov, Gao Wei, et al.
Neurobiology of Aging
|
February 7, 2012
Alleles that modulate late life hearing in genetically heterogeneous mice
Jochen Schacht, Richard Altschuler, David T Burke, et al.
Scientific Reports
|
June 27, 2019
Auditory metabolomics, an approach to identify acute molecular effects of noise trauma
Lingchao Ji, Ho-Joon Lee, Guoqiang Wan, et al.
Free Radical Biology & Medicine
|
January 15, 2005
Elevation of superoxide dismutase increases acoustic trauma from noise exposure
Tsuyoshi Endo, Takayuki Nakagawa, Fukuichiro Iguchi, et al.
Nucleic Acids Research
|
August 13, 2015
Structural basis for selective targeting of leishmanial ribosomes: aminoglycoside derivatives as promising therapeutics
Moran Shalev, Haim Rozenberg, Boris Smolkin, et al.
Journal of Medicinal Chemistry
|
March 25, 2009
Development of novel aminoglycoside (NB54) with reduced toxicity and enhanced suppression of disease-causing premature stop mutations
Igor Nudelman, Annie Rebibo-Sabbah, Marina Cherniavsky, et al.
Page
of 6